Literature DB >> 7015131

Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain.

R F Kaiko, S L Wallenstein, A G Rogers, P Y Grabinski, R W Houde.   

Abstract

We designed a study to determine the relative analgesic potency of intramuscular heroin and morphine and to compare mood and side effects in 166 cancer patients with postoperative pain. Heroin was about twice as potent as morphine (95 per cent confidence limits, 1.6 to 2.6 times) in graded-dose, twin-crossover assays. Heroin provided an analgesic peak effect earlier than morphine (1.2 plus or minus 0.08 and 1.5 plus or minus 0.10 hours, respectively [mean plus or minus S.E.M.]). Doses with equal analgesic effects provided comparable improvements in various elements of mood, particularly feelings of peacefulness. Peak mood improvement occurred earlier after heroin than after morphine (1.2 plus or minus 0.10 and 1.8 plus or minus 0.13 hours, respectively). Both analgesia and mood improvement were less sustained after heroin at doses providing equal peak analgesic effects. The drugs shared the most common side effects, with no marked differences in their occurrence; sleepiness was the most frequent side effect after both drugs (46 per cent with each). Heroin has no apparent unique advantages or disadvantages for the relief pain in patients with cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7015131     DOI: 10.1056/NEJM198106183042501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  9 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

2.  Strong analgesics in severe pain.

Authors:  G K Gourlay; M J Cousins
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

3.  Oral narcotic mixtures.

Authors:  E R Hillier
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

Review 4.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

5.  Diamorphine (heroin) and cancer pain.

Authors:  H Merskey
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262

6.  [Drug therapy for tumor pain I. Properties of non-opioids and opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

Review 7.  Drug management of pain in cancer patients.

Authors:  C B Tuttle
Journal:  Can Med Assoc J       Date:  1985-01-15       Impact factor: 8.262

8.  Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations.

Authors:  Timothy B Saurer; Stephanie G Ijames; Donald T Lysle
Journal:  J Pharmacol Exp Ther       Date:  2009-03-03       Impact factor: 4.030

9.  Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.

Authors:  Andrew Scheibe; Shaun Shelly; Tara Gerardy; Zara von Homeyer; Andrea Schneider; Kalvanya Padayachee; Shalon Balaguru Naidoo; Klaas Mtshweni; Ayanda Matau; Harry Hausler; Monique Marks
Journal:  Addict Sci Clin Pract       Date:  2020-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.